Type 1 diabetes

Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes

DiabetologiaPublished Cross-sectional study

Authors' conclusion

This was the largest coordinated effort to examine the presence of enterovirus RNA in the pancreas of organ donors with type 1 diabetes, using a multitude of assays. These findings are consistent with the notion that donors with type 1 diabetes and donors with islet autoantibodies may carry a low-grade enterovirus infection in the pancreas and lymphoid tissues.

Study context

Population
Organ donors with and without T1D (nPOD); pancreas, spleen, pancreatic lymph nodes and duodenum samples
Participants
71 / 22 / 74
Exposure
Enterovirus RNA detection in donors with T1D vs islet autoantibody-positive vs control donors
  • T1Dn = 71
  • Autoantibody-positiven = 22
  • Controln = 74reference
Outcome
Presence of enterovirus RNA in pancreas and lymphoid tissues
Methodological detailsmulticentre (five research laboratories), organ donor tissue study
  • Multicentre (five research laboratories)
  • Organ donor tissue study

Main finding

As reported in the abstract

Enterovirus RNA detected by RT-PCR in pancreas

Single autoantibody-positive vs T1D with insulin-deficient islets: P < 0.001 · Single autoantibody-positive vs Control: P = 0.004

Observational data: associations, not effects.

Further findings

Enterovirus RNA in lymphoid tissues

Pancreatic lymph nodes also positive in some donors
RT-PCR detected enterovirus RNA in spleen of a small number of donors; virus enrichment in cell lines gave much higher spleen positivity, particularly in T1D
Detected strains did not cause typical lytic infection

Original publication

Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes. Diabetologia. Published 17 March 2025. doi:10.1007/s00125-025-06359-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.